BioBridgeXAll companies

AsclepiX Therapeutics, Inc.

Biotechnology company · Bethesda, Maryland, United States

AsclepiX Therapeutics, Inc. is a biotechnology company headquartered in Bethesda, Maryland, United States. Its earliest recorded incorporation is in 2023. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $3.5 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2024.

asclepix.comProfile compiled from public records. Is this your company? Request a correction or update

AsclepiX Therapeutics at a glance

Typebiotechnology company
HeadquartersBethesda, Maryland, United States
Earliest incorporation on record2023
Employees (per SBIR records)3
SEC CIK1697751

What does AsclepiX Therapeutics do?

US government research funding

6 SBIR/STTR small-business research awards from US health agencies, $3.5 million in total (2014 to 2019). NIH funding came from the National Eye Institute, National Cancer Institute.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $10 million sold (2024).

Frequently asked questions about AsclepiX Therapeutics

Where is AsclepiX Therapeutics headquartered?

AsclepiX Therapeutics, Inc. is headquartered in Bethesda, Maryland, United States.

What does AsclepiX Therapeutics do?

AsclepiX Therapeutics, Inc. is a biotechnology company.

When was AsclepiX Therapeutics founded?

The earliest incorporation on record for AsclepiX Therapeutics, Inc. is in 2023, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.